Goldfarma and Davi Laboratories have entered into an agreement for the transfer of marketing licences for the medicines Dexavit and Levoftal.
Since 19 March, Davi Laboratories has taken over responsibility for the promotion and marketing of both medicines in the Portuguese market. From that date onwards, distribution in the market has been the responsibility of the company that acquired the relevant licences.
Events
Goldfarma Comércio de Produtos Farmacêuticos Lda., has notified Infarmed within the scope of the exercise of the activities of Distribution of Medicines and Medical Devices. NIPC 507372328
Goldfarma Comércio de Produtos Farmacêuticos Lda., has notified Infarmed within the scope of the exercise of the activities of Distribution of Medicines and Medical Devices. NIPC 507372328
goldfarma © 2025 all rights reserved
